Matches in SemOpenAlex for { <https://semopenalex.org/work/W4249381330> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4249381330 endingPage "116A" @default.
- W4249381330 startingPage "114A" @default.
- W4249381330 abstract "The effects of fluvastatin, a new fully synthetic inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, on growth and cell-cycle kinetics of porcine and human vascular smooth muscle cells (SMC) were studied by growth curves and flow cytometric determination of cellcycle distribution. Growth curves were obtained from counting after 2, 4, 7, 9, 11, and 14 days of incubation in Dulbecco's minimum essential medium and 10% fetal calf serum (FCS). For cell-cycle phase determination, cells were synchronized in Go by 48 hours of incubation in serum-free medium, then stimulated by incubation in 10% FCS, with or without fluvastatin. There was a concentration-dependent decrease in the proliferation of human and porcine SMC when cells were incubated in the presence of fluvastatin. The reduction in the number of cells was significant with 10−5 M and 10−4 M fluvastatin. The G/S-phase transition of human and porcine vascuar SMC was reduced to 50% of controls by 10−4M fluvastatin, as revealed by cell-cycle analysis. The effects of fluvastatin on growth kinetics and cell-cycle distribution could be completely reversed by the addition of 1 mM mevalonolactone, indicating that the fluvastatin effects are due to specific inhibition of HMG-CoA reductase. The addition of low density lipoprotein as a source of cholesterol failed to support SMC growth and phase transition. Addition of squalene or cholesterol to the culture medium also failed to normalize cell growth. It is concluded that nonsterol products synthesized from mevalonate are necessary for the growth of SMC. HMG-CoA reductase inhibitors, such as fluvastatin, block the synthesis of these nonsterol precursors in human and porcine vascular SMC in vitro and are therefore growth inhibitory." @default.
- W4249381330 created "2022-05-12" @default.
- W4249381330 creator A5027514145 @default.
- W4249381330 creator A5029434634 @default.
- W4249381330 creator A5058012401 @default.
- W4249381330 date "1995-07-13" @default.
- W4249381330 modified "2023-10-14" @default.
- W4249381330 title "Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro" @default.
- W4249381330 doi "https://doi.org/10.1016/s0002-9149(06)80025-1" @default.
- W4249381330 hasPublicationYear "1995" @default.
- W4249381330 type Work @default.
- W4249381330 citedByCount "0" @default.
- W4249381330 crossrefType "journal-article" @default.
- W4249381330 hasAuthorship W4249381330A5027514145 @default.
- W4249381330 hasAuthorship W4249381330A5029434634 @default.
- W4249381330 hasAuthorship W4249381330A5058012401 @default.
- W4249381330 hasConcept C104950815 @default.
- W4249381330 hasConcept C126322002 @default.
- W4249381330 hasConcept C134018914 @default.
- W4249381330 hasConcept C134651460 @default.
- W4249381330 hasConcept C1491633281 @default.
- W4249381330 hasConcept C181199279 @default.
- W4249381330 hasConcept C202751555 @default.
- W4249381330 hasConcept C25642318 @default.
- W4249381330 hasConcept C2776329913 @default.
- W4249381330 hasConcept C2777320049 @default.
- W4249381330 hasConcept C2778417548 @default.
- W4249381330 hasConcept C2779123261 @default.
- W4249381330 hasConcept C2779395532 @default.
- W4249381330 hasConcept C2780361610 @default.
- W4249381330 hasConcept C29537977 @default.
- W4249381330 hasConcept C2992686903 @default.
- W4249381330 hasConcept C55493867 @default.
- W4249381330 hasConcept C62112901 @default.
- W4249381330 hasConcept C71924100 @default.
- W4249381330 hasConcept C86803240 @default.
- W4249381330 hasConceptScore W4249381330C104950815 @default.
- W4249381330 hasConceptScore W4249381330C126322002 @default.
- W4249381330 hasConceptScore W4249381330C134018914 @default.
- W4249381330 hasConceptScore W4249381330C134651460 @default.
- W4249381330 hasConceptScore W4249381330C1491633281 @default.
- W4249381330 hasConceptScore W4249381330C181199279 @default.
- W4249381330 hasConceptScore W4249381330C202751555 @default.
- W4249381330 hasConceptScore W4249381330C25642318 @default.
- W4249381330 hasConceptScore W4249381330C2776329913 @default.
- W4249381330 hasConceptScore W4249381330C2777320049 @default.
- W4249381330 hasConceptScore W4249381330C2778417548 @default.
- W4249381330 hasConceptScore W4249381330C2779123261 @default.
- W4249381330 hasConceptScore W4249381330C2779395532 @default.
- W4249381330 hasConceptScore W4249381330C2780361610 @default.
- W4249381330 hasConceptScore W4249381330C29537977 @default.
- W4249381330 hasConceptScore W4249381330C2992686903 @default.
- W4249381330 hasConceptScore W4249381330C55493867 @default.
- W4249381330 hasConceptScore W4249381330C62112901 @default.
- W4249381330 hasConceptScore W4249381330C71924100 @default.
- W4249381330 hasConceptScore W4249381330C86803240 @default.
- W4249381330 hasIssue "2" @default.
- W4249381330 hasLocation W42493813301 @default.
- W4249381330 hasOpenAccess W4249381330 @default.
- W4249381330 hasPrimaryLocation W42493813301 @default.
- W4249381330 hasRelatedWork W1966834268 @default.
- W4249381330 hasRelatedWork W2008936746 @default.
- W4249381330 hasRelatedWork W2051483798 @default.
- W4249381330 hasRelatedWork W2064649898 @default.
- W4249381330 hasRelatedWork W2078309101 @default.
- W4249381330 hasRelatedWork W2081038112 @default.
- W4249381330 hasRelatedWork W2168843442 @default.
- W4249381330 hasRelatedWork W2169667471 @default.
- W4249381330 hasRelatedWork W2225386332 @default.
- W4249381330 hasRelatedWork W2271148087 @default.
- W4249381330 hasVolume "76" @default.
- W4249381330 isParatext "false" @default.
- W4249381330 isRetracted "false" @default.
- W4249381330 workType "article" @default.